|Drugs of Today|
Drugs of Today
AIMS & ORGANIZATION
Drugs of Today is a peer-reviewed journal with a solid reputation of over 40 years in the scientific publications market. It is a valuable source of information on drugs introduced into the international market. Its updated monographs and articles keep the medical community abreast of the latest developments in diagnosis and treatment across therapeutic areas. This journal includes the following sections:
Monographs, up-to-date reviews on recently approved and launched drugs prepared by leading specialists after a rigorous review of the literature and from information provided by pharmaceutical companies. Updates with new relevant information or on line extensions of marketed drugs (e.g., novel formulations, new indications, etc.) are also published.
Review articles, highlighting the latest developments in the diagnosis and treatment of human diseases, as well as biomarkers for diagnosing diseases, monitoring treatment response, predicting toxicity and identifying candidates for targeted therapy.
Meeting reports, conference reports providing highlights from key congresses and symposia around the world.
SELECTION OF TOPICS TO BE REVIEWED
The Editorial Board comprises major authorities in their field who are selected to ensure that a wide variety of therapeutic areas are covered. The Board members recommend reviews from authorities within their field to guarantee that all topics are covered comprehensively and that all issues of current importance are emphasized. Submitted articles are peer reviewed before publication.
Supplementary issues devoted to recently marketed drugs and symposia proceedings are periodically published. Supplements are written by leading specialists on the basis of current scientific literature and their own experience.
Editor in Chief: G. Escolar Albaladejo, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain
Managing Editor: M.K. Tracy
Assistant Editors: P. Avello, X. Bofill, C. Dulsat, A.I. Graul, E. Torramadé
Editorial Coordinator: C. Todd
Scientific Advisory Board
|© 2021 Clarivate Analytics. All rights reserved.|